ALTRINSIC GLOBAL ADVISORS LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALTRINSIC GLOBAL ADVISORS LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,580,000
-1.2%
27,0000.0%0.05%
+4.2%
Q3 2021$1,600,000
-38.6%
27,000
-10.0%
0.05%
-39.2%
Q2 2021$2,604,000
+5.3%
30,0000.0%0.08%
+1.3%
Q1 2021$2,474,000
-32.0%
30,000
-25.0%
0.08%
-36.6%
Q4 2020$3,637,000
+51.7%
40,000
-33.3%
0.12%
+25.5%
Q3 2020$2,398,000
+16.5%
60,0000.0%0.10%
+8.9%
Q2 2020$2,059,000
+54.5%
60,0000.0%0.09%
+23.3%
Q1 2020$1,333,000
-2.7%
60,000
-14.3%
0.07%
+25.9%
Q4 2019$1,370,000
+26.0%
70,0000.0%0.06%
+23.4%
Q3 2019$1,087,000
-23.5%
70,0000.0%0.05%
-28.8%
Q2 2019$1,421,000
+15.5%
70,0000.0%0.07%
+15.8%
Q1 2019$1,230,000
+37.0%
70,0000.0%0.06%
+32.6%
Q4 2018$898,000
-21.2%
70,0000.0%0.04%
-17.3%
Q3 2018$1,140,000
+101.1%
70,000
+40.0%
0.05%
+136.4%
Q2 2018$567,00050,0000.02%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 569,889$51,820,00067.63%
Johnson & Johnson Innovation - JJDC, Inc. 3,379,064$307,258,00039.62%
Darwin Global Management, Ltd. 952,847$86,642,00024.18%
Redmile Group, LLC 12,629,737$1,148,422,00013.91%
DAFNA Capital Management LLC 334,360$30,403,0009.05%
Casdin Capital, LLC 3,050,000$277,337,0008.22%
Grosvenor Holdings, L.L.C. 1,459,517$132,714,0007.23%
Copernicus Capital Management, LLC 3,240$295,0004.60%
Eversept Partners, LP 399,499$36,326,4444.26%
Ally Bridge Group (NY) LLC 260,000$23,642,0004.05%
View complete list of FATE THERAPEUTICS INC shareholders